26.01.2013
- Pharmaceutical industry productivity is improving as a more targeted approach to drug development yields dividends and regulators offer speedier decisions on medicines that make a...
19.01.2013
- Fighting the flu may soon get easier. As early as next year, more modern and more effective vaccines will hit the market, thanks to investments by the U.S. government and...
16.01.2013
- Drugmakers are betting that a new wave of medicines for cancer, diabetes, heart disease, multiple sclerosis and hepatitis will shape up as tomorrow's blockbusters in the coming 12...
15.01.2013
- AstraZeneca's new chief executive stamped his authority on the struggling drugmaker on Tuesday by removing the heads of research and commercial operations. Pascal Soriot, who took...
15.01.2013
- Swiss drugmaker Roche has hired a leading American academic in a bid to revive part of its research operations which have struggled to shake off a string of high-profile and costly...
14.01.2013
- Almac is pleased to announce the expansion of its drug product Pharmaceutical Development services with the creation of a new non-GMP formulation development facility and two new...
09.01.2013
- Amgen, the world's largest biotechnology company, on Tuesday lowered its outlook for 2012 earnings per share by 10 cents, citing a delay in the impact of a U.S. tax credit for...
08.01.2013
- Actelion, Europe's biggest biotech company, is sticking to its forecast for core earnings to return to growth from 2014 as cost cuts and a new heart and lung treatment offset...
